Aindo
Trieste synthetic data company turning private health data into clinical evidence
Quick Overview
| Company | Aindo SpA |
|---|---|
| Category | Synthetic Data Platforms |
| Headquarters | Trieste, Italy |
| Founded | 2018 |
| EU Presence | Yes - Italy (EU) |
| Data Location | EU servers (per privacy policy) |
| Open Source | No |
| GDPR Compliant | Yes |
| Self-Hosting | Platform page says it can be used locally |
| Main Features | Synthetic cohorts, data completion, bias balancing, external control arms, real-world evidence, clinical language models |
| Pricing | See website; no prices published |
| Best For | Hospitals, pharma and CROs generating evidence from patient data |
| Replaces | Gretel, NVIDIA NeMo Data Designer |
Detailed Review
Aindo started in 2018 at the SISSA school in Trieste as an AI lab and now concentrates on healthcare. The home page is organised around public health, real-world evidence, external control arms and clinical intelligence.
Its about page also names finance and the public sector among the fields it serves, but the commercial message is clinical.
Evidence from synthetic cohorts
Synthetic patient cohorts are offered for observational studies and outcomes research, and synthetic control arms for trials where recruiting a comparator group is hard. The site claims analysis can start immediately instead of waiting months for data access.
Certificates on the table
The compliance section lists Europrivacy under Article 42 GDPR, ISO 27001 for information security and ISO 9001 for quality, and calls the company the first in Europe certified under Europrivacy for synthetic data in healthcare.
Beyond one dataset
The platform page lists data completion, bias balancing and compatibility across formats, and says it can be employed locally to meet an organisation's own privacy measures. Clinical language models trained on real and synthetic data are a newer addition.
Limitations to Consider
The commercial focus is health and life sciences, so general software testing teams are better served by Syntho. No prices, free tier or public documentation of limits were visible, and the evidence claims on the site are vendor statements. Talk to Octopize if you want a published price list.
Who Should Use Aindo
Hospitals, pharmaceutical groups, CROs and public health bodies in Europe that need synthetic cohorts and external control arms from a vendor holding Europrivacy certification.
Pros and Cons
Pros
- Healthcare specialisation
- Europrivacy, ISO 27001 and ISO 9001 listed
- EU-based data processing stated
- Local deployment possible
- Research roots dating to 2018
Cons
- No published pricing
- Clinical focus narrows other uses
- Efficiency claims unverified
- Newer language-model products are less documented
Alternatives to Aindo
Other European synthetic data platforms worth comparing before you decide:
Octopize
France · Avatar anonymisation with synthetic data and public price tiers
Syntho
Netherlands · Masking, rule-based and AI-generated data in one engine
Dedomena
Spain · Madrid platform pairing validation, anonymisation and synthetic data
MOSTLY AI
Austria · Open-source synthetic data SDK plus a managed data platform
See all European synthetic data platforms or compare them directly against Gretel on our alternatives page.
Frequently Asked Questions
Its homepage and solutions are healthcare-led, though the about page also mentions finance and public-sector work.
Europrivacy under Article 42 GDPR, ISO 27001 and ISO 9001, plus a gender equality certification.
No. The pages reviewed ask visitors to contact the company.